Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lewis H. Bender currently holds 33,574 shares of INTERLEUKIN GENETICS INC (ILI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lewis H. Bender has been a net buyer of ILI stock. They have purchased $24.2K and sold $0 worth of shares.
Lewis H. Bender's most recent insider trade was on Mar 6, 2024, when they sold 33,574 shares at $0.00 per share.
Lewis H. Bender serves as Executive at INTERLEUKIN GENETICS INC (ILI). They have executed 15 insider transactions totaling $24.2K over their tenure at the company.
Lewis H. Bender holds the position of Executive at INTERLEUKIN GENETICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Lewis H. Bender has shown a buying trading pattern, with $24.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Lewis H. Bender was on Mar 13, 2009, when they purchased $29.7K worth of ILI shares. This transaction involved 110,000 shares at $0.27 per share.
Lewis H. Bender currently owns 33,574 shares of INTERLEUKIN GENETICS INC (ILI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lewis H. Bender's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lewis H. Bender has 15 Form 4 filings on record as an insider at INTERLEUKIN GENETICS INC.
Set alerts for Lewis H. Bender and 40,000+ other insiders.